Healthcare & Pharma Research with Seniors, Caregivers & Clinicians
Understanding how treatment decisions are made, how medications are adhered to, and how the patient–caregiver–HCP journey unfolds requires more than surveys. It demands deep, qualitative insight from every voice in the room.
Medication adherence, therapy adoption, and care coordination don't happen in isolation. They occur across a complex web of relationships — between an older adult managing a chronic condition, a family caregiver navigating competing responsibilities, and a clinical team working to communicate risk and benefit clearly.
Our research is purpose-built to surface the human dynamics behind those decisions. We go beyond demographics and self-reported behavior to understand the motivations, fears, routines, and relationships that drive real-world healthcare choices — especially among seniors, their caregivers, and the clinicians who guide them.
Seniors
Lived experience, health literacy, and the personal calculus of risk vs. benefit.
Caregivers
Influence on adherence, gatekeeping roles, and emotional load in care decisions.
Clinicians
HCP communication styles, shared decision-making, and prescribing rationale.
What We Explore
Our research spans the full continuum of the patient and care-team journey — from initial awareness of a therapy to long-term adherence and advocacy.
Treatment & Medication Decision-Making
How seniors and caregivers evaluate, accept, or resist recommendations — including the role of past experiences, peer influence, and trust in the healthcare system.
Barriers & Drivers to Adoption
What accelerates or impedes uptake of new therapies, devices, and digital health tools — from injectable anxiety to app fatigue among older adults.
Communication & Education Needs
Where information breaks down — or lands well — across the patient–caregiver–HCP triad, and how to design materials and conversations that build understanding and confidence.
Example Use Cases
Our work spans therapeutic areas and care contexts. Here are two examples of the kinds of studies we conduct regularly for healthcare and pharma clients.
Exploring why some older adults embrace a new injectable therapy while others avoid it — and how the caregiver's presence, language, and confidence level shapes that decision. We uncover emotional barriers, practical concerns, and the moments when HCP communication tips the balance.
Risk–Benefit Conversations Across the Care Team
Understanding how primary care physicians, specialists, and nurses frame risk and benefit when speaking with older patients and their families. We examine language choices, shared decision-making moments, and where miscommunication or hesitation most often occurs in complex condition management.
Methods We Often Use
The right methodology surfaces truths that standard surveys can't reach. We select and blend approaches based on your research questions, your target population, and the relational dynamics at the heart of the care journey.
In-Depth Interviews
One-on-one sessions with seniors, caregivers, or clinicians — conducted in-person, via video, or by phone — to explore lived experience, decision-making processes, and unmet needs in rich, narrative depth.
Dyadic Research
Joint interviews with patient–caregiver pairs to capture real-time relational dynamics, differing perspectives on the same care moment, and how influence flows between the two people most responsible for daily adherence.
HCP–Patient Perspectives
Parallel or triangulated research with clinicians and their patients to map communication gaps, align messaging strategy, and understand how the same information is received and interpreted across the care relationship.
Focused Discussion Groups
Moderated group sessions designed to surface shared norms, social influences, and common barriers — particularly useful for understanding how peer experience shapes therapy acceptance within senior communities.
Let's Talk About Your Study
Whether you're launching a new therapy, redesigning patient education materials, or trying to understand why adherence breaks down at month three — we can help you design a study that gets to the real story.
We work with clinical researchers, medical affairs teams, and study sponsors across a wide range of therapeutic areas and condition types. Tell us about your therapy area, your target population, and what you need to know — and we'll bring the methodology to match.Talk About Your Study